CClinicalTrials.gg
Sign In
RecruitingNCT07442175Updated Mar 2, 2026

Blood Pressure Monitor (TH-75) Atrial Fibrillation Detection Function Clinical Trial

An observational study in Atrial Fibrillation (AF), sponsored by Andon Health Co., Ltd. Recruiting at 1 site in China. Open to participants aged 22 Years and older. Per ClinicalTrials.gov, last updated 2026-03-02.

Sponsored by Andon Health Co., Ltd · Observational

From the registry’s dates

  • Primary completion was expected by Jun 2026, 3 months ago, but the record still lists the study as recruiting.
  • Started Feb 2026; still recruiting 7 months later.
Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
392
Ages
22 Years and older
Sex
All
01

Study summary

This study evaluates the accuracy of a blood pressure monitor in detecting atrial fibrillation by comparing its results with a standard diagnostic method.

02

Conditions studied

  • Atrial Fibrillation (AF)

Browse trials for

03

In context

Atrial Fibrillation

3,870 studies on the registry are indexed under Atrial Fibrillation; 924 are open to participants now.

This study's planned enrollment of 392 is above the median of 300 across 1,363 observational studies indexed under Atrial Fibrillation.

Browse Atrial Fibrillation studies →

Lead sponsor

Andon Health Co., Ltd is the lead sponsor of 19 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
22 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

The study population consists of adults aged 22 years or older with an arm circumference between 22 cm and 42 cm, including individuals diagnosed with atrial fibrillation and individuals without a prior diagnosis of atrial fibrillation, who are able to undergo blood pressure and ECG measurements.

Inclusion criteria

Atrial Fibrillation (AF):

  • Age ≥ 22 years;
  • Arm circumference between 22 cm and 42 cm;
  • Diagnosed with atrial fibrillation by a qualified medical institution.

Non-Atrial Fibrillation:

  • Age ≥ 22 years;
  • Arm circumference between 22 cm and 42 cm;
  • No prior diagnosis of atrial fibrillation.

Exclusion criteria

Exclusion Criteria:

  • Pregnant women
  • Presence of an implanted cardiac pacemaker and/or defibrillator
  • Inability to cooperate with blood pressure measurement or ECG assessment
  • Any condition that, in the opinion of the investigator, makes the participant unsuitable for participation in this clinical study
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
392 participants (estimated)
Patient registry
No

Groups and cohorts

  • Subjects use Blood Pressure Monitor (TH-75) and ECG
06

What researchers measure

Primary outcomes

  1. Accuracy of atrial fibrillation detection by the TH-75 blood pressure monitor, assessed against the prespecified acceptance criteria.

    Time frame: Baseline

07

Study locations

1 of 1 sites recruiting
  • First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
    Tianjin, Tianjin Municipality 300381, China
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07442175
Lead sponsor
Andon Health Co., Ltd
Collaborators
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Responsible party
Sponsor
First posted
Mar 2, 2026
Start date
Feb 9, 2026
Primary completion
Jun 30, 2026 (estimated)
Completion
Jul 30, 2026 (estimated)
Last update
Mar 2, 2026

Study contacts

Jing Li
Contact
lijing@jiuan.com
022-87611660

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Atrial Fibrillation→

Other studies from this sponsor

Andon Health Co., Ltd

Start the discussion